PCV94 THE COST-EFFECTIVENESS OF TITRATION TO GOAL WITH BRAND ROSUVASTATIN COMPARED TO GENERIC SIMVASTATIN IN PATIENTS WITH ELEVATED LOW-DENSITY LIPOPROTEIN CHOLESTEROL- PRIMARY AND SECONDARY PREVENTION IN THE BELGIAN HEALTH CARE SETTING
Abstract
Authors
D Van den Steen C Petit M Lamotte